跳至主要内容
临床试验/NCT00228475
NCT00228475已完成4 期

An Open Single Centre Study to Assess the Concentration of Budesonide in Breast Milk From Asthmatic Women on Maintenance Treatment w/Pulmicort ® Turbuhaler ® at the Dose Levels 200/400 µg Bid

AstraZeneca1 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2004年9月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
AstraZeneca
入组人数
8
试验地点
1
主要终点
The concentration of budesonide in breast milk from asthmatic women

研究概览

简要总结

The purpose to measure the concentration of budesonide in breast milk of asthmatic mothers on their normal maintenance treatment with budesonide (Pulmicort Turbuhaler), and to estimate the exposure of budesonide to infants.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

性别
Female
接受健康志愿者
否

入选标准

  • •Be willing and able to comply with study procedures and provide informed consent.
  • •Be breast-feeding women, aged 18 to 45 years inclusive, and having infants aged 1 to 6 months.
  • •Be asthmatics that have been on maintenance treatment with Pulmicort Turbuhaler 200 or 400 µg bid for at least 3 months prior to visit

排除标准

  • •Clinically relevant abnormalities in physical examination, laboratory assessments, blood pressure or pulse as judged by the investigator.
  • •Clinically relevant disease and/or abnormalities, which in the opinion of the investigator, may either put the patient or infant at risk because of participation in the study or may influence the results of the study or the patient's ability to participate in the study.
  • •A suspected/manifested infection of HIV, hepatitis B or C or other infection according to WHO Risk classification 2-4

结局指标

主要结局

The concentration of budesonide in breast milk from asthmatic women

on maintenance treatment with Pulmicort Turbuhaler

次要结局

  • Level of budesonide to the infant from breast milk concentrations

研究者

发起方
AstraZeneca
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验